OTCPK:ACAR.Q

Stock Analysis Report

Executive Summary

ActiveCare, Inc. provides chronic illness monitoring products and services in the United States and internationally.

Snowflake

Fundamentals

Weak fundamentals or lack of information.

Risks

  • ActiveCare's last earnings update was 379 days ago.
  • ActiveCare is not covered by any analysts.

Share Price & News

How has ActiveCare's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

ACAR.Q

1.2%

US Medical Equipment

-0.6%

US Market


1 Year Return

-95.0%

ACAR.Q

9.7%

US Medical Equipment

0.7%

US Market

ACAR.Q underperformed the Medical Equipment industry which returned 22% over the past year.

ACAR.Q underperformed the Market in United States of America which returned 2% over the past year.


Share holder returns

ACAR.QIndustryMarket
7 Day0%1.2%-0.6%
30 Day0%3.5%4.9%
90 Day0%3.2%1.7%
1 Year-95.0%-95.0%10.6%9.7%3.0%0.7%
3 Year-99.6%-99.6%70.6%65.4%44.8%35.4%
5 Year-99.9%-99.9%139.4%112.2%62.0%44.3%

Price Volatility Vs. Market

How volatile is ActiveCare's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is ActiveCare undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether ActiveCare is trading at an attractive price based on the cash flow it is expected to produce in the future. But as ActiveCare has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of ACAR.Q’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through ActiveCare regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is ActiveCare expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.5%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as ActiveCare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of ACAR.Q’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access ActiveCare's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has ActiveCare performed over the past 5 years?

0.2%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, ActiveCare has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

  • When a company lacks a financial track record, its management’s track record becomes important. Corporate governance also plays an important role in a young business as board members are seen as highly-experienced leaders to help steer the company into the future. Take a look at ActiveCare's' management and board experience and expertise to assess their ability to deliver on their strategic promises.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access ActiveCare's filings and announcements here.
  • Explore strong past performing companies in the Healthcare industry.

Financial Health

How is ActiveCare's financial position?


Financial Position Analysis

Unable to compare short term assets to short term liabilities as ActiveCare has not reported sufficient balance sheet data.

Unable to establish if ActiveCare's long term commitments exceed its cash and other short term assets as ActiveCare has not reported sufficient balance sheet data.


Debt to Equity History and Analysis

Unable to establish if ActiveCare's level of debt is high without past debt data.

Unable to establish if ActiveCare's debt level has increased without past 5-year debt data.

Unable to verify if debt is well covered by operating cash flow as ActiveCare has not reported sufficient balance sheet data.

Unable to confirm if the interest payments on ActiveCare's debt are well covered by earnings due to lack of past financial data.


Balance Sheet

Unable to establish if ActiveCare has a high level of physical assets or inventory without balance sheet data.

Unable to verify if debt is covered by short term assets as ActiveCare has not reported sufficient balance sheet data.


Next Steps

Dividend

What is ActiveCare's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate ActiveCare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate ActiveCare's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as ActiveCare has not reported any payouts.

Unable to verify if ActiveCare's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as ActiveCare has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of ActiveCare's salary, the management and board of directors tenure and is there insider trading?

1.9yrs

Average management tenure


CEO

Mark Rosenblum (65yo)

1.2yrs

Tenure

0

Mr. Mark J. Rosenblum, CPA, joined ActiveCare, Inc. as Chief Executive Officer and Chairman of the Board on December 11, 2017. Mr. Rosenblum served as Chief Financial Officer of Urigen Pharmaceuticals, Inc ...


Management Age and Tenure

1.9yrs

Average Tenure

52.5yo

Average Age

The average tenure for the ActiveCare management team is less than 2 years, this suggests a new team.


Board Age and Tenure

5.9yrs

Average Tenure

63yo

Average Age

The tenure for the ActiveCare board of directors is about average.


Insider Trading

No 3 month insider trading information.


Management Team

  • Mark Rosenblum (65yo)

    Chairman & CEO

    • Tenure: 1.2yrs
  • Jim Dalton (74yo)

    Consultant

    • Tenure: 2.6yrs
    • Compensation: US$1.10m
  • Jeff Peterson (40yo)

    Executive VP & Director

    • Tenure: 4.8yrs
    • Compensation: US$1.58m
  • Marc Bratsman (40yo)

    Part-Time Consultant

    • Tenure: 3.7yrs

Board Members

  • Mark Rosenblum (65yo)

    Chairman & CEO

    • Tenure: 1.2yrs
  • Jonathan Javitt (61yo)

    Member of Advisory Board

    • Tenure: 6yrs
  • Al Lewis

    Member of Advisory Board

    • Tenure: 5.9yrs
  • Bill Nelson (72yo)

    Member of Advisory Board

    • Tenure: 0yrs
  • Gary Gelbfish (60yo)

    Member of Advisory Board

    • Tenure: 0yrs
  • Jim Mason

    Member of Advisory Board

    • Tenure: 6yrs
  • Jeff Peterson (40yo)

    Executive VP & Director

    • Tenure: 4.8yrs
    • Compensation: US$1.58m
  • Isaac Onn (65yo)

    Director

    • Tenure: 1.2yrs
  • Cindy Palmer

    Member of Advisory Board

    • Tenure: 6yrs

Company Information

ActiveCare, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: ActiveCare, Inc.
  • Ticker: ACAR.Q
  • Exchange: OTCPK
  • Founded: 1998
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$59.775k
  • Shares outstanding: 239.10k
  • Website: https://www.activecare.com

Number of Employees


Location

  • ActiveCare, Inc.
  • 1365 West Business Park Drive
  • Suite 100
  • Orem
  • Utah
  • 84058
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ACAR.QOTCPK (Pink Sheets LLC)YesCommon StockUSUSDJan 2010

Biography

ActiveCare, Inc. provides chronic illness monitoring products and services in the United States and internationally. It develops, distributes, and markets biometric monitoring devices to insurance companie ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/02/14 00:33
End of Day Share Price2018/11/19 00:00
Earnings2017/06/30
Annual Earnings2016/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.